ADVERTISEMENT

 

Press Releases

 

9

Feb

2024

Low-dose aspirin during pregnancy appears to have no effect on child’s neurodevelopment

Author: Anonym

Low-dose aspirin during pregnancy is safe, according to a new study published in The American College of Obstetricians and Gynecologists’ Obstetrics and Gynecology. Researchers found that the Bayley Scales of Infant and Toddler Development (Bayley-III) cognitive composite scores indicated no difference when pregnant parents took low-dose aspirin early in pregnancy compared to a placebo. In other words, it neither worsened nor improved a child’s neurodevelopment.

Comments (0)
Number of views (3998)
Article rating: 4.3
Read more

Categories: APhA News

Tags: APhA News

9

Feb

2024

BP improves with patients taking GLP-1, says study

Author: Anonym

Results from a new study published in the American Heart Association’s Hypertension showed that the GLP-1, tirzepatide, reduced 24-hour systolic BP, both at night and in the daytime compared with placebo.

Comments (0)
Number of views (4967)
Article rating: No rating
Read more

Categories: APhA News

Tags: APhA News

5

Feb

2024

Why are cases of syphilis soaring?

Author: Anonym

CDC stated that the United States is seeing the highest incidence of syphilis since 1950. In its new report, the agency maps out an astonishing comeback for a disease that had previously reached near-eradication status.

Comments (0)
Number of views (3347)
Article rating: No rating
Read more

Categories: APhA News

Tags: APhA News

1

Feb

2024

Is naloxone at the counter getting less costly?

Author: Anonym

Patients paid less money out of pocket for naloxone from 2018 through 2022, according to a new analysis published in JAMA. The research, which was based on data from the IQVIA Longitudinal Prescription database, revealed that the mean out-of-pocket cost per prescription declined from $22.51 in 2018 to $10.02 in 2022.

Comments (0)
Number of views (5195)
Article rating: 5.0
Read more

Categories: APhA News

Tags: APhA News

1

Feb

2024

Fresh data finds gabapentin use trends upward in U.S.

Author: Anonym

Incorporating an additional 6 years of data, researchers updated a previously published analysis of gabapentinoid use among Americans.

Comments (0)
Number of views (3163)
Article rating: 4.0
Read more

Categories: APhA News

Tags: APhA News

RSS
First567810121314Last
Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT